CareDx, Inc.
For the period ended Jun 30, 2025. Filed Aug 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 6, 2025
CDNA$84.42+7.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| ExhibitNumber | |
|---|---|
| 3.1(1) | Amended and Restated Certificate of Incorporation. |
| 3.2(2) | Certificate of Amendment to the Amended and Restated Certificate of Incorporation of CareDx, Inc., filed June 17, 2021. |
| 3.3(3) | Certificate of Amendment to the Amended and Restated Certificate of Incorporation, dated June 16, 2023. |
| 3.4(4) | Amended and Restated Bylaws, effective as of March 24, 2023 |
| 4.1(5) | Form of Registrant’s common stock certificate. |
| 4.2(6)# | 2014 Equity Incentive Plan, as amended. |
| 4.3(7)# | Form of Option Agreement under the 2014 Equity Incentive Plan for New Options. |
| 4.4(8)# | 2014 Employee Stock Purchase Plan and forms of agreements thereunder. |
| 4.5(9)# | 2016 Inducement Equity Incentive Plan. |
| 4.6(10)# | CareDx, Inc. 2019 Inducement Equity Incentive Plan. |
| 10.1(11)# | Amendment No. 1 to the CareDx, Inc. 2024 Equity Incentive Plan. |
| 10.2#* | CareDx, Inc. Amended and Restated Outside Director Compensation Policy, as amended and restated effective June 13, 2025. |
| 10.3#* | Offer Letter, dated May 20, 2025, between CareDx, Inc. and Nathan Smith. |
| 10.4#* | Change of Control and Severance Agreement, dated May 20, 2025, between CareDx, Inc. and Nathan Smith. |
| 10.5#* | Confidential Information, Invention Assignment, Non-Competition, and Arbitration Agreement, dated May 20, 2025, between CareDx, Inc. and Nathan Smith. |
| 31.1* | Certification of Periodic Report by Principal Executive Officer under Section 302 of the Sarbanes-Oxley Act of 2002. |
| 31.2* | Certification of Periodic Report by Principal Financial Officer under Section 302 of the Sarbanes-Oxley Act of 2002. |
| 32.1** | Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| 101.INS* | XBRL Instance Document |
| 101.SCH* | XBRL Taxonomy Extension Schema Document |
| 101.CAL* | XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF* | XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB* | XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE* | XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |
| (1) | Incorporated by reference to Exhibit 3.1 to the Registrant’s Form 10-Q filed with the Securities and Exchange Commission (the “SEC”) on August 28, 2014. |
| (2) | Incorporated by reference to Exhibit 3.1 to the Registrant’s Form 8-K filed with the SEC on June 21, 2021. |
| (3) | Incorporated by reference to Exhibit 3.1 to the Registrant’s Form 8-K filed with the SEC on June 20, 2023. |
| (4) | Incorporated by reference to Exhibit 3.1 to the Registrant’s Form 8-K filed with the SEC on March 28, 2023. |
| (5) | Incorporated by reference to Exhibit 4.1 to the Registrant’s Form 10-K filed with the SEC on March 31, 2015. |
| (6) | Incorporated by reference to Exhibit 4.2 to the Registrant’s Form 10-Q filed with the SEC on July 29, 2021. |
| (7) | Incorporated by reference to Exhibit 99(d)(3) to the Registrant’s Form SC TO-I filed with the SEC on October 12, 2017. |
| (8) | Incorporated by reference to Exhibit 4.5 to the Registrant’s Form S-8 filed with the SEC on July 18, 2014. |
| (9) | Incorporated by reference to Exhibit 4.5 to the Registrant’s Form 10-Q filed with the SEC on July 29, 2021. |
| (10) | Incorporated by reference to Exhibit 4.7 to the Registrant’s Form 10-Q filed with the SEC on July 29, 2021. |
| (11) | Incorporated by reference to Exhibit 10.1 to the Registrant’s Form 8-K filed with the SEC on June 12, 2025. |
| # | Indicates management contract or compensatory plan or arrangement. |
| * | Filed herewith. |
| ** | Furnished herewith. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.